Human FcγRI's Role in Malaria Protection
Author Information
Author(s): Richard S. McIntosh, Jianguo Shi, Richard M. Jennings, Jonathan C. Chappel, Tania F. de Koning-Ward, Tim Smith, Judith Green, Marjolein van Egmond, Jeanette H. W. Leusen, Maria Lazarou, Jan van de Winkel, Tarran S. Jones, Brendan S. Crabb, Anthony A. Holder, Richard J. Pleass
Primary Institution: Institute of Genetics, Queen's Medical Centre, University of Nottingham, United Kingdom
Hypothesis
Can fully human antibodies specific for Plasmodium falciparum provide protection against malaria through FcγRI?
Conclusion
The study demonstrates that human FcγRI is crucial for mediating protection against malaria using fully human antibodies.
Supporting Evidence
- Human antibodies were shown to cure lethal malaria infections in transgenic mice.
- Protection was dependent on the presence of human FcγRI.
- The study utilized a novel rodent malaria model to assess antibody efficacy.
- Antibodies were developed from immune Gambian adults using phage display libraries.
- FcγRI recruitment was essential for therapeutic effectiveness of the antibodies.
Takeaway
Scientists created special human antibodies to fight malaria, and they found that these antibodies work best when they connect with a specific part of the immune system called FcγRI.
Methodology
The study involved creating transgenic mice expressing human FcγRI and testing the efficacy of human antibodies against malaria.
Limitations
The study's findings may not fully translate to human responses due to the use of animal models.
Participant Demographics
The antibodies were derived from malaria-immune Gambian adults.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website